Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add semaglutide, the active ingredient in Wegovy and Ozempic, to the "Demonstrable Difficulties for Compounding" list, which would effectively ban compounding pharmacies from producing compounded versions of these medications
While prescription weight loss medications have been on the market for decades, such as phentermine, the newer GLP-1s, including Ozempic (used off-label for weight loss) and Wegovy, have been generally shown to be more effective than previous treatments
Liposomal iron is a great tool when iron levels are low and IV iron is not easily accessible due to cost or access restrictions
With its ability to help patients lose up to 15% of their body weight , it's quickly becoming one of the most sought-after prescription options in obesity medicine
In line with the importance of TXNRD1 in the regulation of ferroptosis and apoptosis in AML cells, auranofin, a TXNRD1 inhibitor, impaired cell viability in AML subtypes dependent on TXRND1 for their protection against ferroptosis [53]